Form 4 for CRM Salesforce
Accepted 2025-10-31 00:00:00 ET · period of report 2025-10-30 · accession 0001108524-25-000199 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-10-31 | 2025-10-30 | CRM | Benioff Marc | COB, CEO, Dir | S - Sale+OE | $256.82 | -2,250 | 11.91M | -0.0% | -$577.8K |
| D | 2025-10-31 | 2025-10-30 | CRM | Benioff Marc | COB, CEO, Dir | M - OptEx | $161.50 | +2,250 | 11.91M | +0.0% | +$363.4K |
| D | 2025-10-31 | 2025-10-30 | CRM | Benioff Marc | COB, CEO, Dir | M - OptEx | $0.00 | -2,250 | 2,372 | -49% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-10-30 | S | D | 698 | $258.29 | 11,911,679 | D | — | — | (F9) Weighted average price. These shares were sold in multiple transactions at prices ranging from $257.8943 to $258.8715 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. (F2) Shares held in the reporting person's name or in the Marc R. Benioff Revocable Trust. |
| 2 | Common | Common Stock | 2025-10-30 | S | D | 72 | $252.53 | 11,913,545 | D | — | — | (F5) Weighted average price. These shares were sold in multiple transactions at prices ranging from $252.2200 to $253.0287 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. (F2) Shares held in the reporting person's name or in the Marc R. Benioff Revocable Trust. |
| 3 | Common | Common Stock | 2025-10-30 | S | D | 276 | $256.47 | 11,913,235 | D | — | — | (F7) Weighted average price. These shares were sold in multiple transactions at prices ranging from $255.8317 to $256.7796 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. (F2) Shares held in the reporting person's name or in the Marc R. Benioff Revocable Trust. |
| 4 | Common | Common Stock | 2025-10-30 | S | D | 34 | $254.24 | 11,913,511 | D | — | — | (F6) Weighted average price. These shares were sold in multiple transactions at prices ranging from $253.5628 to $254.5280 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. (F2) Shares held in the reporting person's name or in the Marc R. Benioff Revocable Trust. |
| 5 | Common | Common Stock | 2025-10-30 | S | D | 132 | $251.45 | 11,913,617 | D | — | — | (F4) Weighted average price. These shares were sold in multiple transactions at prices ranging from $251.1100 to $251.7289 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. (F2) Shares held in the reporting person's name or in the Marc R. Benioff Revocable Trust. |
| 6 | Common | Common Stock | 2025-10-30 | S | D | 72 | $250.41 | 11,913,749 | D | — | — | (F3) Weighted average price. These shares were sold in multiple transactions at prices ranging from $250.0000 to $250.7500 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. (F2) Shares held in the reporting person's name or in the Marc R. Benioff Revocable Trust. |
| 7 | Common | Common Stock | 2025-10-30 | M | A | 2,250 | $161.50 | 11,913,821 | D | — | — | (F2) Shares held in the reporting person's name or in the Marc R. Benioff Revocable Trust. |
| 8 | Common | Common Stock | 2025-10-30 | S | D | 858 | $257.30 | 11,912,377 | D | — | — | (F8) Weighted average price. These shares were sold in multiple transactions at prices ranging from $256.8903 to $257.8641 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. (F2) Shares held in the reporting person's name or in the Marc R. Benioff Revocable Trust. |
| 9 | Common | Common Stock | 2025-10-30 | S | D | 108 | $258.93 | 11,911,571 | D | — | — | (F10) Weighted average price. These shares were sold in multiple transactions at prices ranging from $258.8894 to $258.9940 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. (F2) Shares held in the reporting person's name or in the Marc R. Benioff Revocable Trust. |
| 10 | Derivative | Non-qualified Stock Option (Right to Buy) | 2025-10-30 | M | D | 2,250 | $0.00 | 2,372 | D | $161.50 · 2020-03-22 to 2026-03-22 | 2,250 Common Stock | (F12) Option vests over four years at the rate of 25% on March 22, 2020, the first anniversary of the holder's date of grant, with the balance vesting in equal monthly installments over the remaining 36 months. |